HER2 MUTATION-RELATED TUMORS
Clinical trials for HER2 MUTATION-RELATED TUMORS explained in plain language.
Never miss a new study
Get alerted when new HER2 MUTATION-RELATED TUMORS trials appear
Sign up with your email to follow new studies for HER2 MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets Tough-to-Treat HER2 cancers, including brain spread
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new drug called IAM1363 for people with advanced cancers that have specific changes in a protein called HER2. The trial will enroll about 243 adults whose cancer has worsened after standard treatments, including …
Matched conditions: HER2 MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: Iambic Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First human trial launches for experimental cancer 'Breaker' drug
Disease control Recruiting nowThis is the first human study testing a new experimental drug called BBO-10203 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and see how the body processes the drug, both alone and when combined with oth…
Matched conditions: HER2 MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC